AU Patent

AU2007291943B2 — Method for reducing incidence or rate of development of skin cancers and related conditions

Assigned to Clinuvel Pharmaceuticals Ltd · Expires 2013-11-14 · 13y expired

What this patent protects

A method for treatment to reduce the incidence or rate of development of skin cancers and related conditions caused by or exacerbated by or associated with UVR-induced skin damage in an immuno-compromised subject, such as an organ transplant patient, comprises the step of adminis…

USPTO Abstract

A method for treatment to reduce the incidence or rate of development of skin cancers and related conditions caused by or exacerbated by or associated with UVR-induced skin damage in an immuno-compromised subject, such as an organ transplant patient, comprises the step of administering to said subject an amount of an alpha-MSH analogue effective to protect the skin of the subject from UVR-induced skin damage.

Drugs covered by this patent

Patent Metadata

Patent number
AU2007291943B2
Jurisdiction
AU
Classification
—
Expires
2013-11-14
Drug substance claim
No
Drug product claim
No
Assignee
Clinuvel Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.